Quick Search

 

 


 

 

Result Summary for 113581

Result Summary
Protocol ID: 113581
Clinical Study ID: FAK113581
Official Title: A Phase I, Randomized, Single-Blind, Placebo-Controlled Dose-Escalation Study to Evaluate the Safety, Pharmacokinetics, Pharmacodynamics and Preliminary Food Effect Following Single Oral Doses of the Focal Adhesion Kinase Inhibitor, GSK2256098, in Healthy Subjects
Phase: phase 1
Study Indications or Diseases:
  • Cancer
Generic Name: GSK2256098
Trade/Product Name: FAK
Approved Drug Label: http://www.gsk.com/products.html
Results Summary: Click here to download result summary. Click here to download result summary.
Citations:

The summaries are in PDF format. If you do not have Adobe® Acrobat® Reader™ installed, you can download it for free.